Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Onodera

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[Positional cloning--current status and future directions]O Onodera, S Tsuji
Human Cell|July 5, 2001
Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseasesT Shimohata, O Onodera, S Tsuji
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 24, 2001
Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseasesT Shimohata, O Onodera, S Tsuji
Neurology|October 1, 1990
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR)K Kaneko, O Onodera, T Miyatake, et al.
Clinical Neurology and Neurosurgery|February 1, 1995
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell lossM Tanaka, K Tanaka, O Onodera, et al.
Neuroreport|November 17, 2001
Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formationK Nozaki, O Onodera, H Takano, et al.
Cell Biochemistry and Biophysics|May 2, 2001
Mutational analysis of X-linked adrenoleukodystrophy geneH Takano, R Koike, O Onodera, et al.
Rinsho Shinkeigaku = Clinical Neurology|July 1, 1995
[Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer]K Tanaka, M Tanaka, O Onodera, et al.
European Journal of Neurology|April 7, 2020
Elevated serum pentraxin 3 levels might predict the diagnosis of branch atheromatous disease at a very early stageI Ninomiya, M Kanazawa, M Uemura, et al.
Annals of the New York Academy of Sciences|February 15, 2000
Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament networkY Nagai, O Onodera, W J Strittmatter, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 1, 1993
[Positional cloning--current status and future directions]O Onodera, S Tsuji
Human Cell|July 5, 2001
Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseasesT Shimohata, O Onodera, S Tsuji
Neuropathology : Official Journal of the Japanese Society of Neuropathology|February 24, 2001
Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseasesT Shimohata, O Onodera, S Tsuji
Neurology|October 1, 1990
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR)K Kaneko, O Onodera, T Miyatake, et al.
Clinical Neurology and Neurosurgery|February 1, 1995
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell lossM Tanaka, K Tanaka, O Onodera, et al.
Neuroreport|November 17, 2001
Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formationK Nozaki, O Onodera, H Takano, et al.
Cell Biochemistry and Biophysics|May 2, 2001
Mutational analysis of X-linked adrenoleukodystrophy geneH Takano, R Koike, O Onodera, et al.
Rinsho Shinkeigaku = Clinical Neurology|July 1, 1995
[Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer]K Tanaka, M Tanaka, O Onodera, et al.
European Journal of Neurology|April 7, 2020
Elevated serum pentraxin 3 levels might predict the diagnosis of branch atheromatous disease at a very early stageI Ninomiya, M Kanazawa, M Uemura, et al.
Annals of the New York Academy of Sciences|February 15, 2000
Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament networkY Nagai, O Onodera, W J Strittmatter, et al.
Pageof 10